Ignite Creation Date:
2024-05-06 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 2:24 PM
Study NCT ID:
NCT05228158
Status:
RECRUITING
Last Update Posted:
2023-12-18
First Post:
2022-01-27
Brief Title:
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 EZH2 Gene Mutation in Japan
Sponsor:
Eisai Co Ltd
Organization:
Eisai Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-16
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-27
First Submit QC Date:
January 27 2022
Study First Post Date:
2022-02-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-15
Last Update Post Date:
2023-12-18
Last Update Post Date Type:
ACTUAL